Eusa Pharma

Brooks Automation, with its corporate headquarters in Chelmsford, Mass., provides hardware and software products, and integrated solutions and services to manufacturers of semiconductor and other complex manufacturing industries. The industries include flat panel display, data storage, automotive, aerospace, defense, life science and medical device industries, with a major focus on the semiconductor capital equipment for the original equipment manufacturers. Established in 1978, its software solutions support business strategies ranging from enterprise performance management and supply chain execution to lean manufacturing and closed-loop automation. Its solution functionality includes automated activity management, maintenance and material management, scheduling, advanced process control, equipment automation, engineering data analysis, and simulation. The company's tool automation products include vacuum and atmospheric robots, cluster tool platforms and modules, equipment front end modules and ultraclean environments for isolating processing equipment. Brooks Automation s automation hardware products include advanced material handling systems, wafer sorting systems, and reticle handling and storage systems.

Ocular Therapeutix, Inc., based in Bedford, MA, is a pioneering company specializing in ophthalmology, particularly in the development of innovative therapies for retinal diseases. With a strong focus on redefining treatment and improving long-term visual outcomes, the company leverages its expertise to enhance clinical trial design and execution. The firm is recognized for its versatile ELUTYX technology platform, which creates sustained release therapies aimed at expanding treatment options across various ocular conditions. Ocular Therapeutix is rapidly growing and offers exciting career opportunities, emphasizing a culture of diversity, equity, and inclusion within its workforce. Generated from the website

Partner Therapeutics Inc., located in Lexington, MA, is a commercial biotechnology company dedicated to enhancing the lives of patients suffering from cancer and other serious diseases. The company focuses on developing innovative therapies, including its lead products LEUKINE and Zenocutuzumab, to address critical medical needs. With a commitment to advancing patient care, Partner Therapeutics engages in collaborative partnerships and rigorous clinical research efforts. The organization actively seeks talented professionals to contribute to its mission across the biopharma value chain. Generated from the website